Molecular formula: | C37H44N8O4 |
Average mass: | 664.811 |
Monoisotopic mass: | 664.348552 |
ChemSpider ID: | 58145210 |
1 of 1 defined stereocentres
1434048-34-6
[RN]2-[3′-(Hydroxymethyl)-1-methyl-5-({5-[(2S)-2-methyl-4-(3-oxetanyl)-1-piperazinyl]-2-pyridinyl}amino)-6-oxo-1,6-dihydro-3,4′-bipyridin-2′-yl]-7,7-dimethyl-3,4,7,8-tetrahydro-2H-cyclopenta[4,5]pyrrolo[1 ,2-a]pyrazin-1(6H)-on
[German]
[ACD/IUPAC Name]2-[3′-(Hydroxymethyl)-1-methyl-5-({5-[(2S)-2-methyl-4-(3-oxetanyl)-1-piperazinyl]-2-pyridinyl}amino)-6-oxo-1,6-dihydro-3,4′-bipyridin-2′-yl]-7,7-dimethyl-3,4,7,8-tetrahydro-2H-cyclopenta[4,5]pyrrolo[1 ,2-a]pyrazin-1(6H)-one
[ACD/IUPAC Name]2-[3′-(Hydroxyméthyl)-1-méthyl-5-({5-[(2S)-2-méthyl-4-(3-oxétanyl)-1-pipérazinyl]-2-pyridinyl}amino)-6-oxo-1,6-dihydro-3,4′-bipyridin-2′-yl]-7,7-diméthyl-3,4,7,8-tétrahydro-2H-cyclopenta[4,5]pyrrolo[1 ,2-a]pyrazin-1(6H)-one
[French]
[ACD/IUPAC Name]2H-Cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-1(6H)-one, 2-[1,6-dihydro-3′-(hydroxymethyl)-1-methyl-5-[[5-[(2S)-2-methyl-4-(3-oxetanyl)-1-piperazinyl]-2-pyridinyl]amino]-6-oxo[3,4′-bipyridin]-2′-yl]-3,4,7,8 -tetrahydro-7,7-dimethyl-
[ACD/Index Name]E9L2885WUL
fenebrutinib
[INN]fenebrutinib
[Spanish]
[INN]fénébrutinib
[French]
[INN]fenebrutinibum
[Latin]
[INN]фенебрутиниб
[Russian]
[INN]فينيبروتينيب
[Arabic]
[INN](S)-2-(3′-(hydroxymethyl)-1-methyl-5-((5-(2-methyl-4-(oxetan-3-yl)piperazin-1-yl)pyridin-2-yl)amino)-6-oxo-1,6-dihydro-[3,4′-bipyridin]-2′-yl)-7,7-dimethyl-3,4,7,8-tetrahydro-2H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-1(6H)-one
1-(1-naphthyl)ethanone;1-Acetonaphthone
1434048-34-6 (free base)
1′-Acetonaphthone
A0A090N8Q0_HUMAN
BTK_HUMAN
CP4B1_HUMAN
Cytochrome P450 4B1
fénébrutinib
Fenebrutinib free base
fenebrutinibum
KCNH2_HUMAN
Tyrosine-protein kinase BTK
фенебрутиниб
فينيبروتينيب
非奈替尼
[Chinese]